Received May 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | 3334Y | — |
inadvertently administered a third dose of Shingrix to a patient; wrong vaccine administered; This non-serious case was reported by a nurse via call center representative and described the occurrence of extra dose administered in a 61-year-old female patient who received Herpes zoster (Shingrix) (batch number 3334Y, expiry date 25-MAR-2027) for prophylaxis. Co-suspect products included Varicella zoster vaccine live (Oka/Merck) (Varivax) for prophylaxis. Previously administered products included Shingrix (received 1st dose on 26-MAR-2024) and Shingrix (received 2nd dose on 28-MAY-2024). Concomitant products included VARICELLA ZOSTER VACCINE (VARICELLA VACCINE). On 14-MAY-2025, the patient received the 3rd dose of Shingrix. On an unknown date, the patient received Varivax. On 14-MAY-2025, an unknown time after receiving Shingrix, the patient experienced extra dose administered (Verbatim: inadvertently administered a third dose of Shingrix to a patient) and wrong vaccine administered (Verbatim: wrong vaccine administered). The outcome of the extra dose administered and wrong vaccine administered were not applicable. Additional Information: GSK receipt date: 14-MAY-2025 and 15-MAY-2025 The reporter reported that the patient received 3rd dose of Shingrix vaccine which led to, extra dose administered. She had received her first dose of the varicella vaccine on 6th March 25 and had been scheduled for her second dose of varicella on 14th May 2025. When asked, the nurse did not provide a reason why the patient had received the varicella vaccine after the Shingrix vaccination.
VARICELLA VACCINE